Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
Life Biosciences tests ER-100, a gene therapy that aims to restore vision by rejuvenating damaged retinal neurons.
If you are over forty, you know the feeling. It starts subtly — a menu held just a little further away at dinner, or the ...
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after ...
WVU School of Medicine researchers, backed by a three-year $1.4M National Eye Institute grant, are developing a gene therapy to treat PROM1-linked inherited blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results